|
L.A. Yusupova, Z.Sh. Garayeva, E.I. Yunusova, G.I. Mavlyutova, L.I. Fatkhutdinova
Discoid lupus erythematosus
|
10-14 |
|
S.I. Surkichin, R.Yu. Mayorov, M.I. Arabadzhyan
Overview of laser and phototherapy techniques for the treatment of onychomycosis
|
15-20 |
|
Yu.I. Matushevskaya
Laser therapy and phototherapy for rosacea
|
21-26 |
|
N.V. Sturov, S.V. Popov, I.Yu. Shmelkov
Modern approaches to the treatment and prevention of fungal urinary tract infections
|
27-33 |
ORIGINAL ARTICLES |
|
N.O. Pereverzina, L.S. Kruglova, T.V. Korotaeva, A.M. Lila
Systematic review and meta-analysis: predictors of psoriatic arthritis
|
34-40 |
|
S.I. Surkichin, L.S. Kruglova, I.A. Apolikhina
The effectiveness of the combined use of topical glucocorticosteroid and photodynamic therapy in vulvar lichen sclerosus
|
41-47 |
|
L.S. Kruglova, D.V. Zaslavsky, N.O. Pereverzina, Yu.A. Sokolovskaya
Skin barrier disorders in atopic dermatitis: from the history of the study to the development of «emollients plus»
|
48-54 |
|
A.M. Dogov, N.N. Murashkin, E.T. Ambarchyan, R.Yu. Nezhvedilova, D.V. Fedorov
Mental status and quality of life in pediatric patients with alopecia areata: a cross-sectional (questionnaire) study
|
55-61 |
|
L.S. Kruglova, E.A. Shatokhina
The key role of an emollient with an active antipruritic component in the strategy for improving the quality of life of patients of the older age group with itching against the background of xerosis
|
62-68 |
|
A.L. Bakulev, M.V. Bakuleva
The effectiveness of combined treatment of rosacea using neodymium laser and photodynamic therapy
|
69-72 |
|
L.A. Novikova, E.V. Dontsova, A.V. Chernov, O.S. Saurina, V.G. Dontsov, T.I. Pogodaeva
Features of the cytokine status, lipid peroxidation and the state of the antioxidant system in patients with true eczema
|
73-77 |
|
S.I. Surkichin, E.V. Kruglik
The effectiveness of cryolipolysis in excess local fat deposits
|
78-81 |
|
O.B. Tamrazova, A.S. Stadnikova, A.V. Taganov, E.A. Glukhova, A.G. Sukhotina, A.M. Sadovnikova
Secondary infection in allergic dermatoses, variety of forms and individual choice of therapy
|
82-90 |
|
|
A.A. Ter-Ovakimyan, M.S. Kruglova
Historical background of clinical and preclinical studies of drugs for medical use
|
91-93 |
|
K.S. Titov, V.V. Glumsky, M.M. Zapirov, E.Yu. Neretin, D.N. Grekov
Amelanotic melanoma: current state of the problem
|
94-99 |
|
I.S. Vladimirova
Psoriasis, metabolic syndrome and COVID-19: a case report
|
100-103 |
|
E.V. Ikonnikova, N.E. Manturova, L.S. Kruglova, A.L. Rodina
Injectable lipolytics and complications from their use
|
104-110 |
|
E.V. Okhanova, E.A. Shatokhina, A.A. Sherstnev, A.M. Kovrigina
Difficulties in diagnosis and treatment of primary skin lymphoma (clinical case)
|
112-115 |
|
S.F. Gladkov, N.K. Perevoshchikova, Yu.S. Pichugina
Experience with phage monotherapy in a patient with atopic dermatitis: a clinical case
|
116-119 |
Русский
